There are many emerging targets showing promising results in the effort to modify the pathological effects associated with AD. Many of the trials also provided evidence of the clinical effects of such drugs reducing pathological outcomes, which was often demonstrated as an improvement of cognition.
No takes yet. Share an insight, caveat, or question.
West et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: